- Home
- CXT vs SRRK Comparison
CXT vs SRRK Comparison
Compare CXT & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CXT
- SRRK
- Stock Information
- Founded
- CXT 1855
- SRRK 2012
- Country
- CXT United States
- SRRK United States
- Employees
- CXT N/A
- SRRK N/A
- Industry
- CXT Office Equipment/Supplies/Services
- SRRK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CXT Industrials
- SRRK Health Care
- Exchange
- CXT Nasdaq
- SRRK Nasdaq
- Market Cap
- CXT 2.6B
- SRRK 2.9B
- IPO Year
- CXT N/A
- SRRK 2018
- Fundamental
- Price
- CXT $46.61
- SRRK $32.81
- Analyst Decision
- CXT Strong Buy
- SRRK Strong Buy
- Analyst Count
- CXT 3
- SRRK 6
- Target Price
- CXT $87.67
- SRRK $42.17
- AVG Volume (30 Days)
- CXT 426.6K
- SRRK 1.5M
- Earning Date
- CXT 05-07-2025
- SRRK 05-06-2025
- Dividend Yield
- CXT 1.46%
- SRRK N/A
- EPS Growth
- CXT N/A
- SRRK N/A
- EPS
- CXT 3.19
- SRRK N/A
- Revenue
- CXT $1,486,800,000.00
- SRRK N/A
- Revenue This Year
- CXT $3.11
- SRRK N/A
- Revenue Next Year
- CXT $5.35
- SRRK $601.05
- P/E Ratio
- CXT $14.59
- SRRK N/A
- Revenue Growth
- CXT 6.86
- SRRK N/A
- 52 Week Low
- CXT $41.54
- SRRK $6.76
- 52 Week High
- CXT $67.01
- SRRK $46.98
- Technical
- Relative Strength Index (RSI)
- CXT 45.48
- SRRK 54.04
- Support Level
- CXT $42.91
- SRRK $28.79
- Resistance Level
- CXT $47.04
- SRRK $34.63
- Average True Range (ATR)
- CXT 2.21
- SRRK 2.21
- MACD
- CXT 0.45
- SRRK 0.86
- Stochastic Oscillator
- CXT 88.02
- SRRK 84.73
About CXT Crane NXT Co.
Crane NXT Co is a industrial technology company that provides proprietary and trusted technology solutions to secure, detect, and authenticate what matters to its customers. It is a pioneer in proprietary micro-optics technology for securing physical products, and its sophisticated electronic equipment and associated software leverages proprietary core capabilities with detection and sensing technologies. The company operates in two segments which are Crane Payment Innovations (CPI) and Security and Authentication Technologies.
About SRRK Scholar Rock Holding Corporation
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.